NCT06862050 BREATHE Free: a Pilot Feasibility Trial
| NCT ID | NCT06862050 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Augusta University |
| Condition | Smoking Cessation; Tobacco Dependence |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-03-01 with a primary completion date of 2026-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall purpose of this pilot study is to assess the feasibility and acceptability of an in-person faith-based intervention to help people stop tobacco use. The study will address use of different types of tobacco products, such as smoking combustible cigarettes, cigarillos and little filtered cigars, and using/vaping electronic nicotine delivery systems (vape pens, e-cigs, and JUUL). The intervention consists of 12 weekly meetings in which participants will go through BREATHE Free, a study guide curriculum designed to teach character strengths and promote resilience. This pilot research will provide information and practical lessons on how to improve Breathe Free implementation, increase engagement of the local people, and maximize their benefit. The main questions it aims to answer are: * Do participants find BREATHE Free curriculum acceptable, engaging and helpful to stop tobacco use? * Do participants who complete BREATHE Free curriculum smoke fewer cigarettes per day? Researchers will assign participants to either BREATHE Free curriculum or usual care. Participants will: * Be taught BREATHE Free curriculum or be given information and referral to tobacco quit line * BREATHE Free group will attend 12 group meetings held on the university campus * All participants will answer interview questions related to tobacco use, character strengths and resilience * Expired Carbon Monoxide (CO) will be assessed in all participants.
Eligibility Criteria
Inclusion Criteria: * Daily use of one or more tobacco products * Valid home address in Augusta or the CSRA * Functioning telephone number * Speak, read, write in English Exclusion Criteria: * Current use of tobacco cessation medications * Enrolled in tobacco treatment program
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06862050 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation; Tobacco Dependence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06862050 currently recruiting?
Yes, NCT06862050 is actively recruiting participants. Contact the research team at bmajeed@augusta.edu for enrollment information.
Where is the NCT06862050 trial being conducted?
This trial is being conducted at Augusta, United States.
Who is sponsoring the NCT06862050 clinical trial?
NCT06862050 is sponsored by Augusta University. The trial plans to enroll 90 participants.